Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)
Clinical trial NCT01012934 · COMPLETED
Trial details
- NCT number
- NCT01012934
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2002-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.